The relationship of academia and companies covered in Nature Biotechnology
A news feature in Nature Biotechnology (subscription required for full text) discusses the potential perils of academia and companies getting into bed with each other in these financially straightened times, and the need for especially careful management of competing interests.
The article discusses a number of recent issues that have stirred American Universities including AMSA's rating of medical schools' conflict of interest policies, and the uncovering of payments to three Harvard psychiatrists from pharnaceutical companies.
The article notes that "many of the problems may stem from a lack of consistent practice and oversight. Industry and academic scientists may have broadly similar goals, but a rushed process can lead to problems and misunderstandings."